[1]石文杰,吳麗麗,張 麗,等.無抽搐電休克治療對精神分裂癥患者主觀舒適度、個人和社會功能、泌乳素的影響[J].醫學信息,2019,(22):69-71.[doi:10.3969/j.issn.1006-1959.2019.22.022]
 SHI Wen-jie,WU Li-li,ZHANG Li,et al.Effect of Electroconvulsive Therapy without Convulsion on Subjective Comfort,Personal and Social Function,and Prolactin in Patients with Schizophrenia[J].Medical Information,2019,(22):69-71.[doi:10.3969/j.issn.1006-1959.2019.22.022]
點擊復制

無抽搐電休克治療對精神分裂癥患者主觀舒適度、個人和社會功能、泌乳素的影響()
分享到:

醫學信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期數:
2019年22期
頁碼:
69-71
欄目:
論著
出版日期:
2019-11-15

文章信息/Info

Title:
Effect of Electroconvulsive Therapy without Convulsion on Subjective Comfort,Personal and Social Function,and Prolactin in Patients with Schizophrenia
文章編號:
1006-1959(2019)22-0069-03
作者:
石文杰吳麗麗張 麗袁秀玉黃文忠尹岸民薛 永黃成兵
(江蘇省淮安市第三人民醫院精神科,江蘇 淮安 223000)
Author(s):
SHI Wen-jieWU Li-liZHANG LiYUAN Xiu-yuHUANG Wen-zhongYIN An-minXUE YongHUANG Cheng-bing
(Department of Psychiatry,the Third People's Hospital of Huai'an,Huai'an 223000,Jiangsu,China)
關鍵詞:
無抽搐電休克精神分裂癥個人和社會功能主觀舒適度
Keywords:
No convulsion electroconvulsiveSchizophreniaPersonal and social functionSubjective comfort
分類號:
R749.3
DOI:
10.3969/j.issn.1006-1959.2019.22.022
文獻標志碼:
A
摘要:
目的 探討無抽搐電休克治療精神分裂癥患者的泌乳素、主觀舒適度、個人和社會功能的影響。方法 選擇2017年6月~2019年5月淮安市第三人民醫院收治的60例住院精神分裂癥患者,采用隨機數字表法分為研究組和對照組,各30例。對照組予以抗精神病藥物治療,研究組在藥物治療基礎上予以無抽搐電休克治療,比較兩組治療前后臨床療效、主觀舒適度、個人和社會功能、泌乳素。結果 治療后兩組PANSS量表評分、SWN量表評分和PSP量表評分均較治療前有改善,差異具有統計學意義(P<0.05);治療后研究組PANSS量表評分和血清泌乳素水平低于對照組,而SWN量表評分、PSP量表評分高于對照組,差異具有統計學意義(P<0.05)。結論 無抽搐電休克治療精神分裂癥有助于提高臨床療效,改善患者主觀舒適度、個人和社會功能,減少泌乳素紊亂。
Abstract:
Objective To investigate the effects of non-convulsive electroconvulsive therapy on prolactin, subjective comfort, personal and social function in patients with schizophrenia. Methods 60 patients with schizophrenia admitted to the Third People's Hospital of Huai'an from June 2017 to May 2019 were randomly divided into study group and control group, 30 cases in each group. The control group was treated with antipsychotic drugs. The study group received no convulsion electroconvulsive therapy on the basis of drug treatment. The clinical efficacy, subjective comfort, personal and social functions, and prolactin were compared before and after treatment. Results After treatment, the PANSS scale, SWN scale and PSP scale scores of the two groups were improved compared with those before treatment,the difference was statistically significant (P<0.05). After treatment, the PANSS scale and serum prolactin levels in the study group were lower than those in the control group, while the SWN scale score and PSP scale score were higher than the control group,the difference was statistically significant (P<0.05).Conclusion The treatment of schizophrenia without electroconvulsive convulsions can improve clinical outcomes, improve subjective comfort, personal and social function, and reduce prolactin disorders.

參考文獻/References:

[1]Tan BL,Lee SA,Lee J.Social cognitive interventions for people with schizophrenia:A systematic review[J].Asian J Psychiatr,2018(35):115-131. [2]van Liempt S,Dols A,Schouws S,et al.Comparison of social functioning in community-living older individuals with schizophrenia and bipolar disorder:a catchment area-based study[J].Int J Geriatr Psychiatry,2017,32(5):532-538. [3]吳勇,平軍嬌,杜寶國,等.非典型抗精神病藥對精神分裂癥患者骨代謝的影響[J].臨床精神醫學雜志,2017,27(4):272-274. [4]黃卓瑋,王朔,高作惠.精神分裂癥患者第2代抗精神病藥治療中主觀感受及相關分析[J].臨床精神醫學雜志,2016,26(2):118-120. [5]胡靖,張家秀.精神分裂癥認知測評及矯正對癥狀轉歸的影響[J].中國現代醫學雜志,2019,29(6):100-104. [6]陶領鋼,李啟斌,于海,等.無抽搐電休克治療對精神分裂癥患者短時及瞬間記憶的影響[J].廣西醫學,2018,40(13):1427-1430. [7]Gan JL,Duan HF,Cheng ZX,et al.Neuroprotective Effect of Modified Electroconvulsive Therapy for Schizophrenia:A Proton Magnetic Resonance Spectroscopy Study[J].J Nerv Ment Dis, 2017,205(6):480-486. [8]Kaster TS,Daskalakis ZJ,Blumberger DM.Clinical Effectiveness and Cognitive Impact of Electroconvulsive Therapy for Schizophrenia:A Large Retrospective Study[J].The Journal of Clinical Psychiatry,2017,78(4):e383-e389. [9]Isitt JJ,Nadipelli VR,Kouassi A,et al.Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone:An 8-week,randomized,double-blind, placebo-controlled,multicenter phase 3 study[J].Schizophr Res,2016,174(1-3):126-131. [10]唐偉,楊馥銀,溫娜,等.棕櫚酸帕利哌酮長效針劑與利培酮治療首次發病精神分裂癥患者的隨機對照研究[J].中華精神科雜志,2016,49(2):76-80. [11]李大奇,呂臻,況利,等.MECT聯合rTMS治療對偏執型精神分裂癥患者認知功能的影響[J].重慶醫學,2016,45(26):3631-3633,3637. [12]王碧馨,杜向東.精神分裂癥患者高泌乳素血癥與骨密度水平相關性研究進展[J].精神醫學雜志,2018,31(5):388-391. [13]文啟琴,郭偉堅,符衛仙,等.無抽搐電休克聯合利培酮治療精神分裂癥的療效及對血清泌乳素、認知功能的影響[J].中國醫院用藥評價與分析,2017,17(3):358-360.

相似文獻/References:

[1]鄒超杰,程宇琪.腸道微生物在精神分裂癥中的研究進展[J].醫學信息,2018,(02):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
 ZOU Chao-jie,CHENG Yu-qi.Progress in the Study of Intestinal Microorganism in Schizophrenia[J].Medical Information,2018,(22):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
[2]張 健,江 芮.生活技能訓練對精神分裂癥緩解期患者日常生活能力的影響[J].醫學信息,2018,(03):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
 ZHANG Jian,JIANG Rui.Effect of Life Skills Training on Daily Living Ability of Patients with Schizophrenia in Remission Staged[J].Medical Information,2018,(22):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
[3]沈雪梅.齊拉西酮與奧氮平治療首發精神分裂癥 療效及糖脂代謝的影響觀察[J].醫學信息,2018,(06):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
 SHEN XUE-mei.The Effect of Ziprasidone and Olanzapine in the Treatment of First Episode Schizophrenia and the Effect of Glycolipid Metabolism[J].Medical Information,2018,(22):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
[4]陳功琦,梁道博.利培酮聯合舍曲林治療精神分裂癥陰性癥狀 療效和安全性的Meta分析[J].醫學信息,2018,(10):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
 CHEN Gong-qi,LIANG Dao-bo.Meta Analysis of Efficacy and Safety of Risperidone Combined with Sertraline in the Treatment of Schizophrenia with Negative Symptoms[J].Medical Information,2018,(22):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
[5]孫占娟.精神分裂癥患者的認知康復治療進展[J].醫學信息,2018,(13):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
 SUN Zhan-juan.Progress in Cognitive Rehabilitation Therapy of Schizophrenia Patients[J].Medical Information,2018,(22):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
[6]吳金麗.阿立哌唑的臨床應用[J].醫學信息,2018,(14):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
 WU Jin-li.Clinical Application of Aripiprazole[J].Medical Information,2018,(22):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
[7]宋典雄.激勵理論指導下的護理干預對精神分裂癥患者的影響[J].醫學信息,2018,(18):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
 SONG Dian-xiong.The Effect of Nursing Intervention under the Guidance of Motivation Theory on Patients with Schizophrenia[J].Medical Information,2018,(22):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
[8]凌 梅,劉靜芳.精神分裂癥患者研究伙伴的相關研究進展[J].醫學信息,2018,(19):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
 LING Mei,LIU Jing-fang.Progress in Research on Research Partners in Patients with Schizophrenia[J].Medical Information,2018,(22):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
[9]韓佳睿,張 蘋,張 媛.遲發性運動障礙與DNA甲基化之間關系的研究進展[J].醫學信息,2018,(20):32.[doi:10.3969/j.issn.1006-1959.2018.20.010]
 HAN Jia-rui,ZHANG Ping,ZHANG Yuan.Advances in Research on the Relationship between Tardive Dyskinesia and DNA Methylation[J].Medical Information,2018,(22):32.[doi:10.3969/j.issn.1006-1959.2018.20.010]
[10]陳寬玉,孔 騫,黃玉桃.首發緩解期精神分裂癥患者日常生活模式的調查[J].醫學信息,2019,(04):182.[doi:10.3969/j.issn.1006-1959.2019.04.061]
 CHEN Kuan-yu,KONG Qian,HUANG Yu-tao.Investigation on the Daily Life Pattern of Patients with Schizophrenia in the First Remission Period[J].Medical Information,2019,(22):182.[doi:10.3969/j.issn.1006-1959.2019.04.061]

更新日期/Last Update: 2019-11-15
中国足彩网竞彩